Dr. Nazee Farsi, MD

Dr. Farsi practices at Rhwc Surgery Center, LLC in Laguna Hills, California.

Dr. Farsi's NPI, 1386826881, was assigned on November 27, 2007. Dr. Farsi holds California license A114530.

Dr. Farsi's primary practice is Rhwc Surgery Center, LLC, at 23141 Moulton Pkwy, Laguna Hills, CA 92653 in Orange County. The practice phone is (949) 516-0606.

Dr. Farsi's primary practice is Rhwc Surgery Center, LLC in Laguna Hills, California. Dr. Farsi is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Farsi to 3 more group practices and clinics, 2 medical groups, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farsi practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Farsi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Farsi is licensed in California.

CMS data shows 385 Medicare services from Dr. Farsi across 7 procedure codes in 2024, for 73 Medicare patients. Medicare paid $20,278 for them. Every service was in an office.

CMS counts 73 Medicare patients who saw Dr. Farsi in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have arthritis, and 75% have high blood pressure. 58% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farsi's median patient age at 63, with 77% women.

In 2024, Dr. Farsi wrote 805 Medicare Part D claims for 171 patients. 79% of them were for generic drugs. CMS names the drug for 689 of them, across 16 drugs with 11 or more claims each, at $401,645 in total drug cost. In 2023, CMS named 715 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Farsi for performance year 2024, reported as part of a group. Dr. Farsi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farsi as offering telehealth.

CMS Open Payments shows 345 general payments to Dr. Farsi from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 90% of the total. Amgen Inc. paid the most, $1,955.